SUVRETTA CAPITAL MANAGEMENT LLC 13D and 13G filings for Monte Rosa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 5:30 pm Purchase |
2025-04-09 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
SUVRETTA CAPITAL MANAGEMENT LLC | 3,360,000 5.500% |
3,360,000 (New Position) |
Filing |